,24 In addition to COVID-19 vaccines, Ad vector research and development extends to many other infectious diseases and to therapeutic cancer vaccines, due to their potent induction of cytotoxic CD8+ T cell immunity.25 The gene discussed is CD8A; the disease is cancer.